Company Filing History:
Years Active: 2014-2015
Title: The Innovative Contributions of Ming-Che Tsai
Introduction
Ming-Che Tsai is a prominent inventor based in Taoyuan County, Taiwan. He has made significant contributions to the field of nuclear medicine, particularly in the development of radiotracers for imaging liver cancers. With a total of 2 patents to his name, Tsai's work is paving the way for advancements in medical imaging and treatment.
Latest Patents
Ming-Che Tsai's latest patents include a precursor used for labeling hepatocyte receptors and a method for preparing the same. This precursor is a bifunctional compound that contains a trisaccharide structure and a diamide dimercaptide ligand. The trisaccharide exhibits a high affinity for asialoglycoprotein receptors on the surfaces of hepatocytes, while the NS ligand reacts with radioisotopes to form neutral complexes. This innovative precursor remains on the surfaces of hepatocytes, providing effective radioisotope labeling or treatment for liver cancers. Another notable patent is the radiotracer precursor and method for preparing the same, which involves a precursor SnBZM for a dopamine receptor radiotracer. This precursor includes a tributyltin group that is easily replaceable, allowing for the production of a dopamine receptor radiotracer I-IBZM at a high yield rate through a substitution reaction.
Career Highlights
Ming-Che Tsai is affiliated with the Atomic Energy Council - Institute of Nuclear Energy Research, where he continues to contribute to the advancement of nuclear medicine. His innovative work has garnered attention in the scientific community, particularly for its potential applications in medical diagnostics and treatment.
Collaborations
Throughout his career, Tsai has collaborated with notable colleagues, including Show-Wen Liu and Yu Lung Chang. These collaborations have further enhanced the impact of his research and innovations in the field.
Conclusion
Ming-Che Tsai's contributions to the field of nuclear medicine through his innovative patents are significant. His work not only advances medical imaging techniques but also holds promise for improving treatment options for liver cancers.